Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.

Schmidt, Stefanie J.; Hurlemann, René; Schultz, Johannes; Wasserthal, Sven; Kloss, Christian; Maier, Wolfgang; Meyer-Lindenberg, Andreas; Hellmich, Martin; Muthesius-Digón, Ana; Pantel, Tanja; Wiesner, Pia-Sophie; Klosterkötter, Joachim; Ruhrmann, Stephan; ESPRIT-B1, group (2019). Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial. Early intervention in psychiatry, 13(6), pp. 1404-1415. 10.1111/eip.12781

[img]
Preview
Text
Trial Protocol ESPRIT B1_manuscript.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (918kB) | Preview
[img] Text
eip.12781.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (818kB) | Request a copy

AIM Meta-analyses indicate positive effects of both antipsychotic and cognitive-behavioural interventions in subjects clinically at high risk (CHR) for psychosis in terms of a delay or prevention of psychotic disorders. However, these effects have been limited regarding social functioning and the relative efficacy of both types of interventions remains unclear. Furthermore, neuroprotective substances seem to be a promising alternative agent in psychosis-prevention as they are associated with few and weak side-effects. METHODS In this multi-centre randomized controlled trial (RCT), we investigate the effects of two interventions on transition to psychosis and social functioning: (a) an integrated preventive psychological intervention (IPPI) including stress-/symptom-management and social-cognitive remediation; (b) N-acetyl-l-cysteine (NAC) as a pharmacological intervention with glutamatergic, neuroprotective and anti-inflammatory capabilities. RESULTS This is a double-blind, placebo-controlled RCT with regard to NAC and a single-blind RCT with regard to IPPI using a 2 × 2-factorial design to investigate the individual and combined preventive effects of both interventions. To this aim, a total of 200 CHR subjects will be randomized stratified by site to one of four conditions: (a) IPPI and NAC; (b) IPPI and Placebo; (c) NAC and psychological stress management; (d) Placebo and psychological stress management. Interventions are delivered over 26 weeks with a follow-up period of 12 months. CONCLUSION This paper reports on the rationale and protocol of an indicated prevention trial to detect the most effective and tolerable interventions with regard to transition to psychosis as well as improvements in social functioning, and to evaluate the synergistic effects of these interventions.

Item Type:

Journal Article (Original Article)

Division/Institute:

07 Faculty of Human Sciences > Institute of Psychology > Clinical Psychology and Psychotherapy
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy

UniBE Contributor:

Schmidt, Stefanie Julia

Subjects:

600 Technology > 610 Medicine & health
100 Philosophy > 150 Psychology

ISSN:

1751-7893

Language:

English

Submitter:

Melanie Best

Date Deposited:

30 Mar 2020 08:37

Last Modified:

01 Apr 2020 12:16

Publisher DOI:

10.1111/eip.12781

PubMed ID:

30784233

Uncontrolled Keywords:

N-acetyl-l-cysteine clinical high risk cognitive remediation prevention psychosis social cognition

BORIS DOI:

10.7892/boris.142461

URI:

https://boris.unibe.ch/id/eprint/142461

Actions (login required)

Edit item Edit item
Provide Feedback